Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Maria Paula Henao"'
Publikováno v:
Journal of Allergy and Clinical Immunology: Global, Vol 3, Iss 3, Pp 100293- (2024)
Background: Tixagevimab-cilgavimab is a combination of 2 mAbs against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In December 2021, the Food and Drug Administration issued Emergency Use Authorization for intramuscular injection of t
Externí odkaz:
https://doaj.org/article/27c206029d6241e2bd1c239a4a2a0033
Autor:
William A. Calo, Betsy Aumiller, Andrea Murray, Laurie Crawford, Madeline Bermudez, Lisa Weaver, Maria Paula Henao, Nicole Maurer Gray, Vicki DeLoatch, Darilyn Rivera-Collazo, Janelle Gomez, Jennifer L. Kraschnewski
Publikováno v:
Frontiers in Public Health, Vol 11 (2023)
BackgroundHispanics in Lebanon and Reading, Pennsylvania, experience high levels of socioeconomic and health disparities in risk factors for chronic disease. In 2018, our community-academic coalition “Better Together” received a Racial and Ethnic
Externí odkaz:
https://doaj.org/article/a2239bde79be487b9b9c81ed016a7c89
Publikováno v:
Journal of Allergy and Clinical Immunology. 151:AB26
Publikováno v:
Journal of Allergy and Clinical Immunology. 151:AB42
Autor:
Kevin Diehl, Matthew Norris, Timothy Craig, Jennifer Kraschnewski, Morgan Kim, Maria Paula Henao
Publikováno v:
Journal of Allergy and Clinical Immunology. 149:AB172
Autor:
Maria Paula Henao, Timothy J. Craig, Faoud T. Ishmael, Jennifer L. Kraschnewski, Matthew D. Bolton
Publikováno v:
International Journal of Environmental Research and Public Health
International Journal of Environmental Research and Public Health, Vol 17, Iss 7287, p 7287 (2020)
Volume 17
Issue 19
International Journal of Environmental Research and Public Health, Vol 17, Iss 7287, p 7287 (2020)
Volume 17
Issue 19
Background: Inhaled corticosteroids (ICS) produce local effects on upper airway dilators that could increase the risk of developing obstructive sleep apnea (OSA). Given that the particle size of ICS changes their distribution, the particle size of IC
Autor:
Timothy J. Craig, Maria Paula Henao
Publikováno v:
Allergy
α1‐Antitrypsin deficiency (AATD) predisposes individuals to chronic obstructive pulmonary disease (COPD) and liver disease. Despite being commonly described as rare, AATD is under‐recognized, with less than 10% of cases identified. The following
Publikováno v:
The Journal of Allergy and Clinical Immunology: In Practice. 5:1302-1306
Background Alpha-1 antitrypsin deficiency (AATD) frequently presents as difficult to manage asthma or asthma with fixed obstruction and is well documented as being underdiagnosed in the population. Objective This study aimed to better describe allerg
Autor:
Maria Paula Henao, Timothy J. Craig
Publikováno v:
Allergy and Asthma Proceedings. 38:98-107
Alpha-1 antitrypsin (AAT) is the prototypical protease inhibitor from the serine protease inhibitor (serpin) superfamily that protects lung tissue from proteolytic damage by inhibiting neutrophil elastase. Approximately 1 in 2750 to 1 in 4500 individ
Autor:
Maria Paula Henao, Timothy J. Craig
Publikováno v:
Expert Review of Respiratory Medicine. 10:1281-1294
Alpha-1-antitrypsin deficiency (AATD) is an orphan disease that predisposes individuals to COPD and liver disease. The following is a comprehensive review of AATD from epidemiology to treatment for physicians who treat COPD or asthma. Areas covered: